ELIJAH STEVENS: Open Payments
NPI 1326131954 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,254 in 58 payments from 8 companies in 2025. Trend: 2023 $15,681 · 2024 $27,201 · 2025 $10,254
Speaker / faculty: $4,950Consulting: $2,200Food & beverage: $1,702Travel & lodging: $1,402
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $9,441 |
| Otsuka America Pharmaceutical, Inc. | 7 | $242 |
| ABBVIE INC. | 5 | $199 |
| Alkermes, Inc. | 3 | $152 |
| Teva Pharmaceuticals USA, Inc. | 1 | $97 |
| Axsome Therapeutics, Inc. | 2 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, REXULTI, LYBALVI, AUSTEDO XR, ABILIFY ASIMTUFII, Auvelity, ARISTADA.
Industry payments across NY — which companies pay providers there.
